By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aureus Pharma said today that it will participate in the Biointelligence R&D Programme, a €118.2 million ($159.8 million) European consortium focused on promoting the use of systemic modeling and simulation tools for biomedical databases.

The Paris-based company said that it could receive an estimated €3.5 million for its participation in the program, under which it will contribute knowledge management and content development.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Sponsored by

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.